Literature DB >> 20020744

Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring.

Kyunggon Kim1, Sang Jin Kim, Hyeong Gon Yu, Jiyoung Yu, Kyong Soo Park, In-Jin Jang, Youngsoo Kim.   

Abstract

Multiple reaction monitoring was used to verify target proteins in 3 groups of vitreous and plasma samples from 3 stages of diabetic retinopathy: macular hole (nondiabetic control), nonproliferative diabetic retinopathy, and proliferative diabetic retinopathy. Twelve target proteins were quantified using triple quadrupole LC-MS/MS and 3 methods to determine the transitions (information-dependent analysis, the MIDAS workflow, and the PeptideAtlas database). This study might be the first MRM experiment to analyze large numbers of clinical vitreous and plasma samples for biomarker verification. Consequently, several biomarker candidates were identified for use in further applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020744     DOI: 10.1021/pr901013d

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  18 in total

Review 1.  Protein analysis by shotgun/bottom-up proteomics.

Authors:  Yaoyang Zhang; Bryan R Fonslow; Bing Shan; Moon-Chang Baek; John R Yates
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

2.  Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.

Authors:  Ju Yeon Lee; Jin Young Kim; Gun Wook Park; Mi Hee Cheon; Kyung-Hoon Kwon; Yeong Hee Ahn; Myeong Hee Moon; Hyoung-Joo Lee; Young Ki Paik; Jong Shin Yoo
Journal:  Mol Cell Proteomics       Date:  2011-09-22       Impact factor: 5.911

3.  Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.

Authors:  Anuli Christiana Uzozie; Nathalie Selevsek; Asa Wahlander; Paolo Nanni; Jonas Grossmann; Achim Weber; Federico Buffoli; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

4.  Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS.

Authors:  Chenchen Wang; Cheng S Lee; Richard D Smith; Keqi Tang
Journal:  Anal Chem       Date:  2012-11-20       Impact factor: 6.986

Review 5.  Plasma kallikrein-kinin system and diabetic retinopathy.

Authors:  Jia Liu; Edward P Feener
Journal:  Biol Chem       Date:  2013-03       Impact factor: 3.915

Review 6.  Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.

Authors:  Tujin Shi; Dian Su; Tao Liu; Keqi Tang; David G Camp; Wei-Jun Qian; Richard D Smith
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

7.  Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach.

Authors:  Meng-Ting Yang; Wei-Hung Chang; Tien-Fen Kuo; Ming-Yi Shen; Chu-Wen Yang; Yin-Jing Tien; Bun-Yueh Lai; Yet-Ran Chen; Yi-Cheng Chang; Wen-Chin Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

8.  Novel serum proteomic signatures in a non-human primate model of retinal injury.

Authors:  Jeffrey J Dunmire; Rachida Bouhenni; Michael L Hart; Bassam T Wakim; Anthony M Chomyk; Sarah E Scott; Hiroshi Nakamura; Deepak P Edward
Journal:  Mol Vis       Date:  2011-03-23       Impact factor: 2.367

9.  Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients.

Authors:  Jonghwa Jin; Yun Hyi Ku; Yikwon Kim; Yeonjung Kim; Kyunggon Kim; Ji Yoon Lee; Young Min Cho; Hong Kyu Lee; Kyong Soo Park; Youngsoo Kim
Journal:  Exp Diabetes Res       Date:  2012-03-27

10.  Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.

Authors:  Hyunsoo Kim; Kyunggon Kim; Su Jong Yu; Eun Sun Jang; Jiyoung Yu; Geunhee Cho; Jung-Hwan Yoon; Youngsoo Kim
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.